BRD is one of the most severe and costly diseases in the livestock industry. Infection is caused by a number of pathogens and can be fatal if left untreated. Every instance of BRD leads to a drastic reduction in profits due to losses in productivity. Resilient Biotics is developing non-antibiotic, precision microbial therapeutics to prevent and treat BRD.
Resilient currently has a number of live microbial therapeutics that have been lab validated against dominant BRD pathogens.
Resilient BRD Therapeutic
Live microbiome therapeutic
Compatible with normal cattle processing
Microbiome Partnership Opportunities
Resilient Biotics has interest in establishing partnerships with animal health companies to apply its proprietary technologies to the discovery and development of disruptive microbiome therapeutics. Interested in partnering with Resilient Biotics? Please fill out our contact form and we will be in touch with you.
Control of opportunistic respiratory pathogens
e.g. porcine pneumonia, canine otitis media
Control pathogens, improve rumen & intestinal health
e.g. calf scours, aquaculture applications
Reduce skin inflammation and chronic infection
e.g. canine atopic dermatitis